Orphan drugs in Australia

被引：6
|
作者：
Herkes, Geoffrey K. [1 ,2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia
[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia
[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia
来源：
EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期
关键词：
Orphan drug program; review; rare diseases; oncology;
D O I：
10.1080/21678707.2016.1257383
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1195 / 1197
页数：3
相关论文
共 50 条
  • [41] Crowd Funding for Orphan Drugs: The Case of Baby Pia
    Pinxten, Wim
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Variables affecting pricing of orphan drugs: the Italian case
    Claudio Jommi
    Elisabetta Listorti
    Federico Villa
    Simone Ghislandi
    Armando Genazzani
    Agnese Cangini
    Francesco Trotta
    Orphanet Journal of Rare Diseases, 16
  • [43] Access to orphan drugs - comparison across Balkan countries
    Pejcic, Ana V.
    Iskrov, Georgi
    Jakovljevic, Mihajlo Michael
    Stefanov, Rumen
    HEALTH POLICY, 2018, 122 (06) : 583 - 589
  • [44] Methods and criteria for the assessment of orphan drugs: a scoping review
    Mohammadshahi, Marita
    Olyaeemanesh, Alireza
    Ehsani-Chimeh, Elham
    Mobinizadeh, Mohammadreza
    Fakoorfard, Zeinab
    Akbari Sari, Ali
    Aghighi, Mohammad
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2022, 38 (01)
  • [45] Analysing criteria for price and reimbursement of orphan drugs in Spain
    Badia, Xavier
    Gil, Alicia
    Luis Poveda-Andres, Jose
    Shepherd, John
    Tort, Marina
    FARMACIA HOSPITALARIA, 2019, 43 (04) : 121 - 127
  • [46] Orphan drugs: major development challenges at the clinical stage
    Fonseca, Diogo A.
    Amaral, Ines
    Pinto, Ana Catarina
    Cotrim, Maria Dulce
    DRUG DISCOVERY TODAY, 2019, 24 (03) : 867 - 872
  • [47] Determinants of orphan drugs prices in France: a regression analysis
    Korchagina, Daria
    Millier, Aurelie
    Vataire, Anne-Lise
    Aballea, Samuel
    Falissard, Bruno
    Toumi, Mondher
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [48] Rare diseases and orphan drugs in Eastern European Countries
    Stefanov, Rumen
    Taruscio, Domenica
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2009, 6 (04): : 289 - 293
  • [49] Common drug review recommendations for orphan drugs in Canada: basis of recommendations and comparison with similar reviews in Quebec, Australia, Scotland and New Zealand
    McCormick, John I.
    Berescu, L. Diana
    Tadros, Nabil
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [50] Access to orphan drugs despite poor quality of clinical evidence
    Dupont, Alain G.
    Van Wilder, Philippe B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 488 - 496
12345